Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
SeedToB Capital
AddedFeb 15, 2024
UpdatedJul 3, 2026
SeedToB Capital

SeedToB Capital

Operating

SeedToB Capital: An AI venture fund specializing in healthcare-focused artificial intelligence initiatives.

Location
Suwanee, GA, US
Founded
2020
Firm
Compare
Portfolio
Employees
Website

SeedToB Capital is an AI venture fund specializing in healthcare-focused artificial intelligence initiatives. The firm typically invests in Seed and Series A rounds, leveraging its expertise to support early-stage companies in the AI healthcare sector. SeedToB Capital's investments range from pre-seed to Series B, providing crucial funding to startups aiming to innovate within the healthcare industry.

Notable portfolio companies include Biotia, Canid, Feel Therapeutics, Gritwell, OncoLens, Shimmer, Strive, and Zeit Medical. The firm's key partners are the founders of Jvion, a leading prescriptive AI company in healthcare. SeedToB Capital offers value-add services such as leveraging their extensive network and tactical expertise to help founders efficiently navigate towards Series B funding. Their investment philosophy centers on harnessing AI's transformative potential to drive significant impact in healthcare.

SeedToB Capital - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments14
Current Portfolio Count13
Total Portfolio Exits0

Top Investment Stages

Seed4 (28.6%)
Series A4 (28.6%)
Series Unknown4 (28.6%)
Pre-Seed1 (7.1%)
Series B1 (7.1%)

Stage Mix

Seed 29%Series A 29%Series Unknown 29%Pre-Seed 7%Series B 7%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Shimmer logo

Shimmer

Feel Therapeutics logo

Feel Therapeutics

Canid logo

Canid

eMedEvents logo

eMedEvents

AngelEye Health logo

AngelEye Health

Biotia logo

Biotia

Strive logo

Strive

Mployer Advisor logo

Mployer Advisor

Gritwell logo

Gritwell

Zeit Medical logo

Zeit Medical

Epinoma logo

Epinoma

Moonlight Therapeutics logo

Moonlight Therapeutics

OncoLens logo

OncoLens

SeedToB Capital - Similar Investment Firms

Seae Ventures logo

Seae Ventures

iSeed Ventures logo

iSeed Ventures

iseedvc.com

Boutique Venture Partners logo

Boutique Venture Partners

boutiquevc.com

SeedFolio logo

SeedFolio

Good AI Capital logo

Good AI Capital

goodai.capital

XSeed Capital logo

XSeed Capital

xseedcap.com

JAD Capital logo

JAD Capital

Tunitas Ventures logo

Tunitas Ventures

Jumpstart Capital logo

Jumpstart Capital

jscap.co

StartVenture logo

StartVenture

Seed River logo

Seed River

seedriver.com

HealthTrend Capital logo

HealthTrend Capital

healthtrendcap.com

Endpoint Ventures logo

Endpoint Ventures

endpoint.vc

Seed Capital Partners logo

Seed Capital Partners

Seedway Ventures logo

Seedway Ventures

SeedToB Capital - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified